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Abstract
Triggering receptor expressed on myeloid cells-1 (TREM-1) is a potent amplifier of pro-inflammatory innate immune
reactions. While TREM-1-amplified responses likely aid an improved detection and elimination of pathogens, excessive
production of cytokines and oxygen radicals can also severely harm the host. Studies addressing the pathogenic role of
TREM-1 during endotoxin-induced shock or microbial sepsis have so far mostly relied on the administration of TREM-1
fusion proteins or peptides representing part of the extracellular domain of TREM-1. However, binding of these agents to
the yet unidentified TREM-1 ligand could also impact signaling through alternative receptors. More importantly,
controversial results have been obtained regarding the requirement of TREM-1 for microbial control. To unambiguously
investigate the role of TREM-1 in homeostasis and disease, we have generated mice deficient in Trem1. Trem12/2 mice are
viable, fertile and show no altered hematopoietic compartment. In CD4+ T cell- and dextran sodium sulfate-induced models
of colitis, Trem12/2 mice displayed significantly attenuated disease that was associated with reduced inflammatory
infiltrates and diminished expression of pro-inflammatory cytokines. Trem12/2 mice also exhibited reduced neutrophilic
infiltration and decreased lesion size upon infection with Leishmania major. Furthermore, reduced morbidity was observed
for influenza virus-infected Trem12/2 mice. Importantly, while immune-associated pathologies were significantly reduced,
Trem12/2 mice were equally capable of controlling infections with L. major, influenza virus, but also Legionella pneumophila
as Trem1+/+ controls. Our results not only demonstrate an unanticipated pathogenic impact of TREM-1 during a viral and
parasitic infection, but also indicate that therapeutic blocking of TREM-1 in distinct inflammatory disorders holds
considerable promise by blunting excessive inflammation while preserving the capacity for microbial control.
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Introduction
Innate immune cells express several cell surface receptors and
intracellular sensing molecules that allow for autonomous recog-
nition of pathogen- and danger-associated molecular patterns
(PAMPs and DAMPs) and initiation of pro-inflammatory anti-
microbial reponses. Toll-like receptors (TLR) and nucleotide-
binding oligomerization domain (NOD)-like receptors, which
recognize a diverse group of highly conserved microbial structures,
represent only two examples of large innate immune receptor
families with activating functions. Over the last decade, an addi-
tional family of evolutionary conserved innate immune receptors
has been identified and characterized, the so-called triggering
receptors expressed on myeloid cells (TREMs). TREMs belong to
the immunoglobulin (Ig) superfamily of receptors and contain both
inhibitory and activating receptors [1,2,3]. In contrast to the fairly
ubiquitously expressed TLRs and NOD-like receptors, expression
of TREMs is restricted to cells of the myeloid lineage [4]. More-
over, based on their capacity to integrate and potently modulate
TLR- and NOD-induced signals, TREMs appear to mainly act as
fine-tuners rather than initiators of inflammatory responses [3,5].
While TREM-1, TREM-2, TREM-3 (in the mouse) receptors
[4,6], and the TREM-1 like transcripts TLT-1 and TLT-2 have
been described [7,8], TREM-1 is the first identified and best
characterized receptor of the TREM family with activating func-
tions. TREM-1 consists of an ectodomain, composed of a single Ig
V-type domain, a transmembrane region and a short cytoplasmic
tail that recruits DAP12 for signaling [4]. TREM-1 is constitu-
tively expressed on neutrophils and on subsets of monocytes and
macrophages, and TREM-1 expression is further upregulated upon
exposure of cells to microbial products [4]. Whereas crosslinking of
TREM-1 with agonistic antibodies alone induces only modest
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cellular activation, TREM-1 potently synergizes with distinct TLR
ligands for a substantial amplification of oxidative burst and pro-
duction of pro-inflammatory mediators such as TNF, IL-1b, IL-6,
IL-8, MCP-1 and Mip-1a [4,9,10].
In vivo, the role of TREM-1 has been mostly characterized in
experimental models of endotoxin-induced shock or microbial
sepsis where blockade of TREM-1 signaling conferred significant
protection [9,11,12]. The detection of TREM-1 in inflammatory
lesions caused by bacterial or fungal agents, but not in psoriasis or
immune-mediated vasculitis [9], has further led to the general
concept that TREM-1 is primarily involved in microbial diseases,
particularly, since elevated levels of the serum soluble form of the
shed TREM-1 surface receptor (sTREM-1) also appear to
associate with bacterial infections in patients with pneumonia or
suspected sepsis [13,14].
However, increasing evidence is now emerging that TREM-1
may additionally play a role in non-infectious inflammatory con-
ditions. Thus, expression of TREM-1 can also be induced by the
non-microbial agent monosodium urate monohydrate crystals
(MSU) or by hypoxic cell culture conditions in vitro [15,16].
Augmented sTREM-1 levels have been reported for patients with
rheumatoid arthritis, acute pancreatitis, chronic obstructive pul-
monary disease and cardiac arrest [17,18,19,20]. Furthermore, we
have previously described an involvement of TREM-1 in human
inflammatory bowel diseases (IBD) and in models of experimental
colitis [21,22,23].
Investigations on the precise function of TREM-1 in distinct
diseases have so far been complicated by the still unidentified
ligand(s) for TREM-1. Putative ligands for TREM-1 have been
described on the surface of human platelets and on murine
granulocytes during experimental peritonitis and endotoxaemia
[12,24,25]. In addition, necrotic cell lysates also appear to stimu-
late pro-inflammatory responses in a TREM-1-dependent manner,
which may relate to association of TREM-1 with the High Mobility
Group Box 1 (HMGB1) protein [26,27]. Hence, it can be speculated
that not only PAMPs but also DAMPs induce signaling via TREM-
1 and that several ligands for TREM-1 may exist.
In the absence of clearly defined ligands for TREM-1, studies
addressing the impact of TREM-1 in disease have so far mostly
relied on the use of TREM-1/Ig fusion proteins or synthetic
peptides mimicking part of the extracellular domain of TREM-1.
Although by the use of these agents substantial protection from
endotoxin-induced shock, microbial sepsis or experimental colitis
could be conferred [9,11,12,22], several aspects regarding the true
biological role of TREM-1 remain unclear. First, considering the
redundancy of innate immune receptor-ligand interactions, the
possibility exists that in these previous studies not only signaling
through TREM-1 but through additional, potentially more rele-
vant receptors was prevented. Second, controversial findings have
been obtained with respect to the impact of impaired TREM-1
signaling on microbial control [9,28,29,30].
In order to investigate the role of TREM-1 in homeostasis and
disease, we have generated a TREM-1-deficient (Trem12/2) mouse
by targeted deletion of exon 2. Here we show, employing distinct
inflammation and infection models ranging from experimental
colitis to infections with Leishmania major, influenza virus and
Legionella pneumophila, that complete absence of TREM-1 signifi-
cantly attenuates morbidity and immune-mediated pathologies
while microbial control remains unimpaired. These findings not
only demonstrate an unanticipated clear role for TREM-1 in
chronic inflammatory disorders, parasitic and viral infections, but
also illustrate the potential for a novel therapeutic intervention in
various disease settings.
Results
Deletion of Trem1 has no apparent impact under
homeostatic conditions
To account for potential embryonically lethal effects of a total
deletion of the Trem1 gene, a targeting vector was designed for
conditional deletion of exon 2 (Fig. S1). Exon 2 encodes the
extracellular domain of TREM-1 and also contains the putative
ligand binding site [31]. Breeding of Trem1+/flox chimeric offspring
mice with deleter mice that expressed Cre ubiquitously yielded
viable Trem1+/2 x Cre+/2 offspring. Moreover, interbreeding of
Trem1+/2 mice gave rise to Trem12/2 mice at the expected
Mendelian frequencies, and Trem12/2 mice were equal in size,
weight and fertility to littermate Trem1+/+ controls. We thus con-
tinued to characterize Trem12/2 mice with a ubiquitously deleted
Trem1 gene by elementary flow cytometry analyses. Deletion of
Trem1 resulted in a gene-dose-dependent loss of TREM-1 surface
expression by peripheral blood neutrophils and Ly6Clo monocytes
(Fig. 1). Accordingly, TREM-1 was still expressed at ,2-fold
reduced levels in Trem1+/2 mice, while surface TREM-1 expres-
sion was absent on myeloid cells in Trem12/2 mice (Fig. 1).
Absence of Trem1 did not appear to affect the composition of
various immune compartments, since numbers of distinct myeloid
and lymphoid cell subsets isolated from the peripheral blood, bone
marrow (BM) and spleen of Trem12/2 and Trem1+/+ mice were
identical (Fig. S2). However, to formally exclude a potential effect
of TREM-1 on hematopoiesis, the BM of Trem12/2 and Trem1+/+
mice was analysed in more depth with respect to hematopoietic
stem cell and myeloid progenitor numbers following lineage
depletion and depletion of lymphoid progenitors (Fig. 2). Stem
cell-enriched cells were identified by their lineage2 (lin2) Sca-1+ c-
kithi phenotype (LSK cells) while common myeloid progenitors
(CMP), granulocyte/macrophage progenitors (GMP) and mega-
karyocyte/erythrocyte precursors (MEP) were discriminated with-
in the Sca-12 c-kithi population according to their differential
Author Summary
Triggering receptor expressed on myeloid cells-1 (TREM-1)
is an immune receptor expressed by myeloid cells that has
the capacity to augment pro-inflammatory responses in
the context of a microbial infection. While a TREM-1-
amplified response likely serves the efficient clearance of
pathogens, it also bears the potential to cause substantial
tissue damage or even death. Hence, TREM-1 appears a
possible therapeutic target for tempering deleterious host-
pathogen interactions. However, in models of bacterial
sepsis controversial findings have been obtained regarding
the requirement of TREM-1 for bacterial control - depend-
ing on the overall degree of the TREM-1 blockade that was
achieved. In order to conclusively investigate harmful
versus essential functions of TREM-1 in vivo, we have
generated mice deficient in Trem1. Trem12/2 mice were
subjected to experimentally-induced intestinal inflamma-
tion (as a model of a non-infectious, yet microbial-driven
disease) and also analysed following infections with
Leishmania major, influenza virus and Legionella pneumo-
phila. Across all models analysed, Trem12/2 mice showed
substantially reduced immune-associated disease. We thus
describe a previously unanticipated pathogenic role for
TREM-1 also during a parasitic and viral infection.
Importantly, our data suggest that in certain diseases
microbial control can be achieved in the context of
blunted inflammation in the absence of TREM-1.
Characterisation of TREM-1-Deficient Mice
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expression of FccR and CD34, respectively (Fig. 2a). Compared to
Trem1+/+ mice, Trem12/2 mice exhibited equal numbers of LSK
cells, CMP, GMP and MEP (Fig. 2B). Moreover, similar numbers
of colony forming units could be observed in lineage-depleted
(lin2) BM cells isolated from Trem12/2 mice (Fig. 2B). Although
these analyses indicated again that TREM-1 is unlikely to play a
substantial role in hematopoietic processes, we were intrigued by
the selective expression of surface TREM-1 by GMP, but not by
CMP (Fig. 2A). As a final measure, we therefore established mixed
bone marrow chimeras with either Trem12/2 (x GFP2/2) and
Trem1+/+ x GFP+/+ BM cells or, as a control, Trem1+/+ (x GFP2/2)
and Trem1+/+ x GFP+/+ BM cells. Analysis of chimeric mice at 10
and 31 weeks post reconstitution and calculation of the respective
ratios of GFP2 to GFP+ peripheral blood neutrophil, Ly6Chi or
Ly6Clo monocyte numbers demonstrated an equal capacity of
Trem12/2 BM to give rise to distinct myeloid subsets as Trem1+/+
BM. Thus, while the potential role of TREM-1 expression by
GMP still remains to be explored, deficiency in Trem1 does not appear
to affect hematopoietic processes under homeostatic conditions.
We next addressed whether absence of Trem1 could affect other
receptors that use DAP12 for signaling, either by the potential
presence of increased levels of intracellularly available DAP12 or
by the lack of counterregulatory signals conferred by TREM-1.
Indeed, the hyperresponsive phenotype of DAP12-deficient
macrophages is largely ascribed to a lack of inhibitory signals by
TREM-2 which also employs DAP12 [32]. Due to the important
role of TREM-2 in osteoclast formation and function [33,34], we
reasoned that lack of TREM-1 expression in Trem12/2 mice could
possibly manifest in altered osteoclastogenesis. However, as
determined by Xray and MicroCT analyses, no differences in
bone density could be detected between Trem12/2 mice and their
age- and sex-matched Trem1+/+ controls (data not shown).
Taken together, these analyses revealed no apparent phenotype
of Trem12/2 mice under homeostatic conditions.
Trem12/2 x Rag22/2 mice are largely protected from a
CD4 T cell-induced colitis
We have previously demonstrated a substantial accumulation of
TREM-1 expressing macrophages in the inflamed, but not healthy
intestinal mucosa of patients with IBD and of mice with
experimental colitis [22,23]. Hence, one of our major interests
in the characterization of the Trem12/2 mouse was to unambi-
gously investigate the role of Trem1 in the pathogenesis of IBD. To
this end, CD4+ CD252 CD45RBhi T cells were adoptively
transferred into Helicobacter-positive Trem1+/+ x Rag22/2 and
Trem12/2 x Rag22/2 recipient mice and animals were monitored
regularly for clinical signs of colitis. Importantly, whereas Trem1+/+
x Rag22/2 mice lost ,20% of their initial body weight at the end
of the observation period, weight loss in Trem12/2 x Rag22/2 mice
was minimal and only transient (Fig. 3A). Furthermore, shortening
of the colon was substantially attenuated in Trem12/2 x Rag22/2
mice compared to controls (Fig. 3B). While some of the Trem12/2
x Rag22/2 mice still exhibited moderate histopathological signs of
intestinal inflammation, individual parameters of the histopatho-
logical scoring as well as the overall histopathological score were
significantly reduced (Fig. 3C–E).
In order to gain insight in the potential underlying mechanism
of the highly attenuated colitis in Trem12/2 x Rag22/2 mice,
colonic lamina propria cells that were isolated from both groups of
mice in the absence of an adoptive CD4+ T cell transfer (healthy
colon) or 12–13 days post colitis induction were analysed by
FACS. As depicted in Fig. 4A, the colonic lamina propria of
healthy Trem1+/+ x Rag2+/+ mice and Trem12/2 x Rag22/2 mice
contained a similar proportion of CD11b+ MHCIIhi cells and
Gr1+ cells were virtually absent. In contrast, Gr1+ cells, repre-
senting infiltrating Ly6Chi Gr1int monocytes and Ly6Cint Gr1hi
neutrophils, were readily detected in Trem1+/+ x Rag2+/+ mice and
Figure 1. TREM-1 surface expression by peripheral blood
myeloid cell subsets fromwildtype versus Trem1-deficient mice.
Peripheral blood cells obtained from wildtype (Trem1+/+) and Trem1-
deficient (Trem1+/2 and Trem12/2) mice (n = 2 mice for each group)
were stained for surface expression of TREM-1 and analysed by FACS.
(A) Representative gating strategy to identify neutrophils and LyC6lo
and Ly6Chi monocytes. (B) Representative histograms showing TREM-1
surface expression (lines) versus isotype controls (filled histograms). (C)
Mean fluorescence intensity (MFI) of TREM-1 surface expression. Mean
values of n = 2 mice analysed are shown with error bars indicating the
range. Data are representative of several independent analyses.
doi:10.1371/journal.ppat.1003900.g001
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Trem12/2 x Rag22/2 mice at 12–13 days post colitis induction
(Fig. 4A). Notably, the relative frequency of Gr1+ cells among
CD45+ CD11b+ colonic LP cells was ,5-fold lower in Trem12/2 x
Rag22/2 mice (Fig. 4A). In further contrast to the colonic LP of
healthy mice, among LP MHCII+ Gr12 cells of colitic mice two
populations of MHCIIhi Ly6Clo and MHCIIint Ly6Chi cells could
be discriminated, likely representing intestinal macrophages and
monocytes in the process of differentiation (Fig. 4A) [35,36]. Also
within this gate of MHCII+ Gr12 cells, substantial differences
could be detected between the two groups of mice. Accordingly,
the relative frequency of MHCIIint Ly6Chi cells was increased in
colitic Trem1+/+ x Rag22/2 mice whereas Trem12/2 x Rag22/2
mice exhibited a larger proportion of MHCIIhi Ly6Clo macro-
phages (Fig. 4A).
When colonic LP cells of n= 9 mice of both groups were
systematically analysed at 12–13 days post colitis induction,
substantially reduced numbers of various cell subsets could be seen
in Trem12/2 x Rag22/2mice (Fig. 4B). Thus, Trem12/2 x Rag22/2
mice not only exhibited reduced infiltrating CD4+ T cells but also
significantly decreased numbers of neutrophils, Ly6Chi monocytes
and MHCIIint Ly6Chi cells (Fig. 4B). These differences were not
apparent for the colonic LP of healthy Trem1+/+ x Rag22/2 and
Trem12/2 x Rag22/2 mice which mainly contained MHCIIhi
Ly6Clo cells anyway (Fig. 4A and 4C).
Figure 2. Unimpaired hematopoiesis in Trem12/2 mice. (A) Representative dot plots show the FACS-based identification of lineage-depleted
(lin2) Sca1+ c-kithi (LSK) cells and lin2 Sca12 c-Kithi myeloid progenitors in Trem1+/+ (top panels) and Trem12/2 (bottom panels) bone marrow (BM)
following lineage depletion and depletion of lymphoid progenitors by MACS. Common myeloid progenitors (CMP), granulocyte-macrophage
progenitors (GMP) and megakaryocyte/erythrocyte progenitors (MEP) were further discriminated according to their expression of FccR and CD34.
Filled histograms show TREM-1 surface expression by LSK cells, CMP, GMP and MEP progenitors from Trem12/2 mice in comparison to Trem1+/+ mice
(lines). (B) Absolute cell numbers of total BM cells, lin2 BM cells, lin2 Sca12 c-kithi myeloid progenitors, LSK cells, CMP, GMP and MEP and colony
forming units (CFU) of hematopoietic precursors isolated from the BM of Trem1+/+ and Trem12/2 mice were determined as described in the Materials
and Methods section. Mean values of n = 2 mice analysed are shown with error bars indicating the range. (C) Mixed BM chimeras were generated by
i.v. transfer of 1:1 mixed Trem1+/+ x GFP+/+ and Trem12/2 x GFP2/2 BM cells (white circles, dotted lines) into irradiated recipient mice. As control, and
to account for potential interfering effects of the GFP expression, mixed BM from Trem1+/+ x GFP+/+ and Trem1+/+ x GFP2/2 mice (black circles and
lines) was transferred into additional recipient mice. BM chimeras were analyzed after 10 and 31 weeks of chimerism. Neutrophils, Ly6Chi and Ly6Clo
monocytes were identified in the peripheral blood according to the depicted gating strategy and the GFP2 : GFP+ cell ratio in the respective cell
subsets was determined. Mean values of n = 4–5 mice analyzed per group are shown with error bars indicating the SEM. ns, no statistically significant
difference. Data depicted in Figure 2 are representative of two independent experiments.
doi:10.1371/journal.ppat.1003900.g002
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To gain more insight which myeloid TREM-1-expressing cell
subset could potentially be involved in driving intestinal inflam-
mation in Trem1+/+ x Rag22/2 mice, TREM-1 surface expression
was analysed on colonic LP neutrophils, Ly6Chi monocytes as well
as CD11b+ Ly6C+ Gr12 and CD11b+ Ly6C2 Gr12 cells. As
reported previously [23,37], in the healthy colonic LP TREM-1
expression was hardly detectable owing to the absence of infil-
trating neutrophils and Ly6C+ cells (Fig. 4A and 4D). In colitic
Trem1+/+ x Rag22/2 mice, TREM-1 expression was observed on
neutrophils, Ly6Chi monocytes and CD11b+ Ly6C+ Gr12 cells
(Fig. 4D). Moreover, CD11b+ Ly6C2 Gr12 cells, likely represent-
ing intestinal macrophages, that were isolated from colitic Trem1+/+
x Rag22/2 mice exhibited a ,3-fold upregulated expression of
surface TREM-1 (Fig. 4D).
In line with the reduced infiltrating cell numbers, mRNA expres-
sion for various innate and adaptive pro-inflammatory chemokines
and cytokines was significantly decreased in the lamina propria of
Trem12/2 x Rag22/2 compared to Trem12/2 x Rag22/2 mice
(Fig. 4E).
Dextran sodium sulfate (DSS)-induced colitis is
attenuated in Trem12/2 mice
While protection from colitis in Trem12/2 x Rag22/2 mice was
associated with reduced expression of several pro-inflammatory
mediators, previous data generated in our laboratory have
demonstrated that TNF produced by nonlymphoid cells plays a
non-redundant pathogenic role in the CD4+ T cell transfer model
of colitis since Tnf2/2 x Rag22/2 mice are completely protected
from colitis induction [38]. However, in acute models of intestinal
inflammation such as the DSS-induced colitis, Tnf2/2 mice
exhibit aggrevated disease [39,40], presumably, because early anti-
microbial and repair responses following DSS-induced breaching
of the epithelial barrier are fundamentally impaired. Due to the
central function of TREM-1 in amplifying pro-inflammatory
cytokine production and oxidative burst, we hypothesized that
during acute intestinal inflammation complete absence of Trem1
could also prove detrimental. Intriguingly, although upon admin-
istration of 3% DSS Trem12/2 mice initially lost weight to a
similar extent as Trem1+/+ mice, weight loss was considerably
attenuated at 7 days post colitis induction and at 9 days Trem12/2
mice had already improved again (Fig. 5A). In Trem12/2 mice,
shortening of the colon was markedly attenuated and total
histopathological colitis scores were significantly decreased
(Fig. 5B and 5C–E). Furthermore, analogous to the CD4 T cell-
induced colitis (Fig. 4E), TREM-1 deficiency resulted in reduced
colonic mRNA expression of several pro-inflammatory mediators
(Fig. 5F). Hence, in contrast to Tnf2/2 mice [39,40], Trem12/2
mice still showed an adequate host response to DSS-induced
epithelial injury while exhibiting reduced immune-mediated
pathologies.
Infection with Leishmania major leads to smaller
inflammatory lesions with decreased neutrophilic cellular
infiltrates in Trem12/2 mice
The observations made in the acute DSS model of colitis raised
our interest whether Trem12/2 mice would also be able to control
bona fide microbial infections, in particular, since maximal silencing
of TREM-1 by a siRNA approach had proven deleterious in a
fecal peritonitis model [29]. Since the rapid kinetics of this model
hardly allowed to simultaneously look at beneficial effects of the
Trem1 deficiency on immune-mediated tissue damage or to assess
potential adverse consequences for the priming of adaptive
immune responses, we chose the Leishmania major infection model.
Following infection with L. major, C57BL/6 mice develop local
cutaneous lesions that spontaneously resolve within 4–8 weeks.
Central to the resolution is the TNF-mediated control of the early
inflammatory response or the clearance of neutrophils and the
later IFNc-mediated and Th1-driven elimination of the parasite
by infected macrophages [41,42].
Figure 3. Trem12/2 x Rag22/2 mice are protected from a CD4+ T
cell-induced colitis. Colitis was induced in Trem1+/+ x Rag22/2 (filled
circles) and Trem12/2 x Rag22/2 mice (white circles) by i.p. injection of
26105 CD4+ CD45RBhi T cells. (A) Weight loss relative to the initial body
weight. Mean values of n = 9 mice analysed per group are shown with
error bars indicating the SEM. (B) Colon lengths were determined in
individual mice (symbols). Lines show mean values for each group of
mice. (C) Representative H&E-stained colonic tissue sections of a
Trem1+/+ x Rag22/2 (histopathological score: 14) and Trem12/2 x Rag22/2
mouse (histopathological score: 2). (D) Total histopathological scores.
Symbols show total scores for individual mice and lines indicate the
mean value for each group of mice. Histopathological scores were
determined for individual mice by a pathologist according to parameters
defined in the Materials and Methods section. (E) Individual parameters
of histopathological scoring. Columns show mean values for n= 9 mice
analysed per group and error bars indicate the SEM. ****, p,0.0001; ***,
p,0.001; **, p,0.01. One representative experiment out of three
independent experiments is shown.
doi:10.1371/journal.ppat.1003900.g003
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Upon injection of 36106 L. major promastigotes s.c. in the
footpad of Trem1+/+ and Trem12/2 mice, an attenuation in lesion
development was apparent in Trem12/2 mice already at 14 days
post infection. From thereof, Trem12/2 mice showed a signifi-
cantly decreased lesion size (Fig. 6A). Notably, however, parasite
counts did not differ between Trem12/2 and Trem1+/+ mice
(Fig. 6B). We further analysed the cellular composition of infected
footpads from Trem12/2 and Trem1+/+ mice at 21 days post
infection. While the overall cell counts were comparable, the
cellular infiltrate in Trem12/2 mice exhibited,3-fold reduced neu-
trophil numbers (Fig. 6C). To look at the potential impact of the
Trem1-deficiency on the priming of Th1 responses, expression of
IFNc was analysed in cells isolated from the draining lymph node.
The frequency of IFNc-secreting CD4+ T cells was similar in
Trem12/2 and Trem1+/+ mice (Fig. 6D). In addition, comparable
levels of IFNc were detected in cells of both groups of mice upon
re-stimulation in vitro with the parasitic antigen (Fig. 6D). These
data are in line with comparable parasite killing observed in
Trem12/2 and Trem1+/+ mice. Thus, in the L. major infection
model, absence of Trem1 does not appear to have adverse
consequences on the priming of adaptive immune responses and
on parasite control while neutrophil-mediated inflammatory lesion
development is substantially reduced.
Stimulation via TREM-1 induces TNF secretion and
resistance to apoptosis in SCF-condHoxb8 progenitor-
derived neutrophils
The reduced neutrophil numbers at L. major-infected sites and
the decreased lesion size in Trem12/2 mice agree with the notion
that neutrophils play a central role in inflammatory lesion
development. Indeed, the presence of non-healing lesions in L.
major susceptible BALB/c strains is associated with elevated
numbers of neutrophils [43]. Since neutrophils constitutively
express high levels of TREM-1 (Fig. 1B, 4D), we aimed to
investigate the consequences of TREM-1-mediated stimulation on
their functional responses in more detail. Analysis of mouse
neutrophils has so far been complicated by the limited numbers of
cells that can be retrieved from the peripheral blood, their short
life span or the distinct differentiation stages of BM-derived
neutrophils. Hence, we made use of a recently described system by
which neutrophils can be differentiated ex vivo in large numbers
using conditional Hoxb8 [44]. Using a slightly modified protocol,
BM-derived progenitors were lentivirally transduced with condi-
tional Hoxb8 in the presence of SCF, resulting in immortalized
myeloid progenitor lines, termed SCF-condHoxb8. Upon shutdown
of Hoxb8 expression by withdrawal of 4-OHT, cells differentiate
into mature neutrophils in the presence of SCF. As shown in
Figure 7A and 7B, withdrawal of 4-OHT in fact induced the
appearance of cells bearing the characteristic phenotype of mouse
neutrophils after in vitro differentiation for 5 days. Moreover,
Trem1+/+ SCF-condHoxb8-derived mature neutrophils also expressed
distinct levels of surface TREM-1 (Fig. 7B). Stimulation of Trem1+/+,
but not of Trem12/2, SCF-condHoxb8-derived mature neutrophils
with a plate-bound agonistic anti-TREM-1 antibody resulted in
pronounced mRNA expression of iNOS and TNF (Fig. 7C) and
induced rapid secretion of TNF at levels comparable to those
triggered by LPS (Fig. 7D).
Since neutrophil survival versus apoptosis could represent a
deciding factor in the control of inflammation not only in the L.
major infection model but also in the pathogenesis of experimental
colitis [45], we compared the susceptibility of Trem1+/+ and
Trem12/2 neutrophils to spontaneous apoptosis. Following pro-
longed culture of fully differentiated SCF-condHoxb8-derived
neutrophils in vitro, an increasing and comparable frequency of
AnnexinV+DAPI+ cells was detected for Trem1+/+ and Trem12/2
neutrophils (Fig. 7E). However, in the presence of TREM-1-
mediated stimulation a reduced apoptosis rate based on dimin-
ished Caspase 3/7 activity could be observed for Trem1+/+ neu-
trophils (Fig. 7F). Furthermore, agonistic anti-TREM-1 stimula-
tion of Trem1+/+ but not Trem12/2 neutrophils resulted in ,2-fold
upregulated mRNA expression of Myeloid Cell Leukemia-1 (Mcl-
1) (Fig. 7G), analogously to what has recently been described for
human TREM-1-stimulated monocytes [46].
Thus, TREM-1-mediated activation of mouse neutrophil appears
to contribute to their survival.
Influenza virus-infected Trem12/2 mice exhibit reduced
morbidity but an equal capacity for viral clearance
Intrigued by the substantially diminished inflammatory lesions,
yet intact parasite clearance in L. major-infected Trem12/2 mice,
we aimed to substantiate these findings in an altogether different
infection model. Since high expression of TREM-1 by alveolar
macrophages and previously published data [28,30,47,48] suggest
a potential role for TREM-1 in lung inflammatory responses, we
infected Trem1+/+ and Trem12/2 mice intratracheally with
50 PFU influenza A virus PR8. Hypothermia and body weight
loss, which are characteristically associated with experimental
influenza virus infection, were observed in Trem1+/+ mice at 7 days
post infection (Fig. 8A and 8B). While the body temperature also
dropped in Trem12/2 mice, a quicker recovery from hypothermia
was seen in the Trem12/2 group (Fig. 8A). Moreover, weight loss
in Trem12/2 mice was significantly attenuated and Trem12/2 mice
further exhibited reduced levels of IL-6 in bronchoalveolar lavage
fluid (BALF) at 10 days post infection (Fig. 8B and 8C). Notably, in
spite of the reduced morbidity observed, Trem12/2 mice were
equally competent in clearing the influenza virus infection as
Trem1+/+ controls (Fig. 8D).
Trem12/2 mice are equally capable of clearing L.
pneumophila as Trem1+/+ controls
After having established that deficiency in TREM-1 attenuates
disease but does not impair pathogen control during a parasitic
Figure 4. Upon colitis induction, Trem12/2 x Rag22/2 mice exhibit substantially reduced inflammatory infiltrates and diminished
expression of pro-inflammatory mediators. (A–C) Lamina propria cells were isolated from the colon of Trem1+/+ x Rag22/2 and Trem12/2 x
Rag22/2 mice 12–13 days post adoptive transfer of colitogenic CD4 T cells or from untransferred mice (healthy colons) and analysed by FACS. (A)
After exclusion of doublets and dead cells, CD11b+ cells were discriminated from CD4+ T cells and further subgated into MHCIIlo Gr1+ (gate 1) and
MHCIIhi Gr12 (gate 2) cells. In gate 1, monocytes and neutrophils were identified according to their Ly6Chi Gr1int and Ly6Cint Gr1hi phenotype,
respectively. In gate 2, MHCII+ cells were further subdivided into two populations of MHCIIint Ly6Chi and MHCIIhi Ly6Clo cells. (B, C) Absolute numbers
of total cells recovered from individual mice (symbols; lines indicate mean values per group) and mean values 6 SEM for CD45+ cells, CD4+ T cells,
CD11b+ cells and subsets defined within the CD11b+ gate as illustrated in (A). Per group, n = 9 mice adoptively transferred with CD4 T cells (B) and
n= 4 untransferred (C) mice were analysed. (D) TREM-1 surface expression by neutrophils (Ly6Cint Gr1hi), monocytes (Ly6Chi Gr1int) and CD11b+ Gr12
Ly6C+ versus Ly6C2 subsets identified in the lamina propria (according to the gating strategy depicted in D) of colitic (n = 9) versus healthy (n = 4)
Trem1+/+ x Rag22/2 mice. (E) Colonic tissues were assessed for the expression of pro-inflammatory mediators by qRT-PCR. Bars show mean values 6
SEM for n = 9 mice. ***, p,0.001; **, p,0.01; *, p,0.05. N.D. = not determined due to insufficient cell numbers.
doi:10.1371/journal.ppat.1003900.g004
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Figure 5. Attenuated dextran sodium-sulfate (DSS)-induced colitis in Trem12/2 mice. Colitis was induced in Trem1+/+ and Trem12/2 mice
by administration of 3% DSS in the drinking water for 5 days, followed by 4 days on regular tap water. (A) Weight loss relative to the initial body
weight. Mean values of n = 17 (Trem1+/+) and n= 16 (Trem12/2) mice are shown with error bars indicating the SEM. (B) Colon lengths were
determined in individual DSS-treated and untreated control mice (symbols). Lines show mean values for each group of mice. (C) Representative H&E-
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and viral infection, we last sought to address the significance of
TREM-1 in a bacterial infection model. Indeed, controversial
results have been obtained with respect to the importance of
TREM-1 in microbial control following infection of experimental
animals with Pseudomonas aeruginosa [28,30]. Here, we employed a
Legionella pneumophila infection model which also causes severe upper
airway inflammation in permissive mice and critically depends on
neutrophil-mediated control [49,50,51]. As shown in Figure 9, at 3
days post infection with 56106 CFU of L. pneumophila, CFU and
neutrophil numbers in the BALF did not significantly differ between
Trem1+/+ and Trem12/2 mice. Furthermore, at day 5 post infection
CFU were reduced to, 500/BALF in both groups of mice with no
significant differences observed between Trem1+/+ and Trem12/2
mice (data not shown).
Discussion
The significance of TREM-1 as a central amplifier of acute pro-
inflammatory responses during endotoxin-induced shock and
microbial sepsis is well established. However, increasing evidence,
stained colonic tissue sections of a Trem1+/+ (histopathological score: 13) and Trem12/2 mouse (histopathological score: 5.5). (D) Total
histopathological scores. Symbols show total scores for individual mice and lines indicate the mean value for each group of mice. Histopathological
scores were determined for individual mice by a pathologist according to parameters defined in the Materials and Methods section. (E) Individual
parameters of histopathological scoring. Columns show mean values and error bars indicate the SEM. (F) Colonic tissues were assessed for the
expression of pro-inflammatory mediators by qRT-PCR. Bars show mean values 6 SEM for n = 7 mice per group from one independent experiment.
(A, B, D) Pooled data from three independent experiments are shown. ****, p,0.001; ***, p,0.001; *, p,0.05.
doi:10.1371/journal.ppat.1003900.g005
Figure 6. Trem12/2 mice develop smaller inflammatory lesions and show decreased cellular infiltrates at L. major infection sites. (A)
Trem1+/+ and Trem12/2 mice were inoculated with 36106 L. major promastigotes s.c. in the footpad and lesion development was measured over
time. Each data point represents the mean lesion size6 SEM of n = 5 mice analysed per group. (B) Parasite load was assessed at 35 days post infection
(p.i.) by limiting dilution analysis. (C) Infected footpads from Trem1+/+ and Trem12/2mice (n = 4–5 mice per group) were isolated 21 days p.i., digested
and the cellular content was analysed by flow-cytometry. Data show mean values6 SEM and are representative of two independent experiments. (D)
Draining lymph node cells from Trem1+/+ and Trem12/2mice (n = 4 mice per group) were isolated 35 days p.i.; the frequency of CD4+ IFNc+ T cells was
analysed by intracellular FACS staining or cells were re-stimulated with UV-treated L. major parasites and IFNc levels in the supernatants were
assessed by ELISA. Data show mean values 6 SEM of triplicate measurements. Representative data from one out of three independent experiments
are shown. ***, p,0.001; **, p,0.01; *, p,0.05.
doi:10.1371/journal.ppat.1003900.g006
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Figure 7. TREM-1 mediates TNF secretion and resistance to apoptosis in SCF-condHoxb8 progenitor-derived neutrophils.
SCF-condHoxb8 Trem1+/+ and Trem12/2 progenitor lines were generated by lentiviral transduction of Hoxb8 into BM-derived hematopoietic cells
obtained from the respective mice and cultured in the presence of SCF and 4-hydroxytamoxifen (4-OHT). For in vitro neutrophil differentiation,
SCF-cond Hoxb8 cells were cultured for additional 5–6 days in the absence of 4-OHT. (A) H&E stained cytospins of Trem1+/+ SCF-condHoxb8 progenitor
cells (left) and differentiated neutrophils (right). (B) FACS-based characterization of Trem1+/+ (top panels) and Trem12/2 (bottom panels)
SCF-condHoxb8 progenitor cells (left) and differentiated neutrophils (right). (C) TNF and iNOS mRNA expression by Trem1+/+ and Trem12/2
SCF-condHoxb8 differentiated neutrophils following 2 h stimulation with plate-bound agonistic anti-TREM-1 mAb or an isotype control antibody was
determined by qRT-PCR. (D) TNF secretion by Trem1+/+ and Trem12/2 SCF-condHoxb8 differentiated neutrophils in response to stimulation with an
agonistic anti-TREM-1 mAb or an irrelevant isotype control mAb in the presence or absence of LPS (100 ng/ml) was assessed by ELISA. (E)
Spontaneous apoptosis of Trem1+/+ and Trem12/2 SCF-condHoxb8 neutrophils in vitro was analysed at 5 days post differentiation with SCF (0 h) and
the indicated time-points beyond by FACS-based determination of AnnexinV and DAPI double-positive cells. Bars show mean values 6 SEM for n = 3
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including the recently reported association of TREM-1 with the
DAMP protein HMGB1 [26,27], also suggests a potential role for
TREM-1 during non-infectious and chronic inflammatory condi-
tions. In line with this notion, we have previously described a
crucial involvement of TREM-1 in IBD as based on the significant
amelioration of experimental colitis upon blockade of TREM-1
with the antagonistic LP17 peptide [22]. Blocking TREM-1
signaling by daily administration of TREM-1-Ig fusion proteins or
synthetic analogues in chronic disease models is not only costly
and straining but also fails to cover for the possibility that the yet
unidentified TREM-1 ligand may signal through alternative
receptors.
Here, we have generated a Trem12/2 mouse to unambiguously
investigate the impact of a complete TREM-1-deficiency on the
pathogenesis of experimental colitis but also of two other distinct
sub-acute disease settings where the role of TREM-1 has so far not
been addressed in vivo, i.e. inflammation induced by a parasitic and
viral infection. Our findings demonstrate that Trem12/2 mice not
only show a highly attenuated CD4+ T cell- and DSS-induced
colitis but also display significantly reduced lesion size and
diminished morbidity during infections with L. major and influenza
virus, respectively.
The substantial attenuation of illness and immune-mediated
pathologies in Trem12/2 mice across these distinct models suggests
a common mechanism by which TREM-1 signaling promotes
inflammation irrespective of the original trigger. Several non-
exclusive scenarios can be considered that may account for the
attenuated disease in Trem12/2 mice: A priori reduced chemotactic
recruitment of Trem12/2 neutrophils and monocytes, diminished
pro-inflammatory activities, and/or reduced life-span of myeloid
cell subsets. Although we observed significantly decreased num-
bers of distinct myeloid cell subsets in the LP of colitic Trem12/2 x
Rag22/2 mice and at L. major-infected sites in Trem12/2 mice, we
consider it unlikely that deficiency in TREM-1 causes an intrinsic
primary defect in chemotaxis. When we analysed L. major infected
sites at an early time-point, i.e. 3 days post infection, no differences
in cellularity were detected between Trem1+/+ and Trem12/2 mice
(data not shown). Moreover, a recent study clearly demonstrated
that TREM-1/3 proteins are not required for transendothelial
migration of neutrophils [30]. Nonetheless, the markedly de-
creased expression of mRNA for monocyte- (CCL2), granulocyte-
(CXCL1, CXCL2, CXCL5) but also T cell (CXCL9) chemoat-
tractants in the LP of Trem12/2 x Rag22/2 mice will in a
secondary manner certainly have contributed to the decreased
accumulation of inflammatory cells. Besides the diminished
expression of chemotactic mediators, the colonic LP of colitic
Trem12/2 x Rag22/2 mice also exhibited substantially reduced
mRNA levels of several innate cytokines, including IL-1b, IL-6
and TNF. The reduced expression of pro-inflammatory mediators
in the entire colonic LP in Trem12/2 x Rag22/2 mice at the late
in vitro replicates from one representative experiment out of three independent experiments. (F) Caspase 3/7 activity was assessed upon 24 h
stimulation of differentiated Trem1+/+ and Trem12/2 SCF-condHoxb8 neutrophils with plate-bound agonistic anti-TREM-1 mAb, an isotype control
antibody, or LPS (100 ng/ml) as a positive survival control. Bars show mean values 6 SEM for n = 3 in vitro replicates from one representative
experiment out of three independent experiments. n.d., not detected. (G) Expression of Mcl-1 mRNA was assessed by qRT-PCR 2 h post stimulation
with plate-bound anti-TREM-1 or an isotype control mAb in the presence or absence of LPS. Bars show mean values 6 SEM of three independent
experiments for anti-TREM-1 vs. isotype control mAb stimulated cells. n.d., not detected. ****, p,0.01; **, p,0.01; *, p,0.05.
doi:10.1371/journal.ppat.1003900.g007
Figure 8. Reduced morbidity but intact viral clearance in influenza virus-infected Trem12/2 mice. Trem1+/+ and Trem12/2 mice were
infected intratracheally with 50 PFU influenza A virus PR8. (A, B) Body temperature and weight loss relative to the initial body weight following
infection. Graphs show pooled data from two independent experiments and mean values6 SEM of n= 10 mice per group. (C, D) Mice were sacrificed
at the indicated time-points post infection. Bars show mean values6 SEM of n = 4 (day 6) and n= 6 (day 10) mice per group. (C) Lung viral titers were
determined by plaque assay on MDCK cells. (D) IL-6 and IL-12 levels in BAL fluid were assessed by ELISA. n.d., not detected. **, p,0.01; *, p,0.05.
doi:10.1371/journal.ppat.1003900.g008
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stage of colitis induction certainly also mirrors the decreased
cellular infiltration. However, considering the capacity of TREM-
1 to augment the production of several chemotactic mediators
either directly in infiltrating myeloid cells or likely also indirectly,
in a paracrine manner (e.g. through secretion of IL-1b) [4,22,52],
we believe that TREM-1-amplified production of pro-inflamma-
tory cytokines represents a key early pathogenic event that will
ultimately determine the later disease course and may largely
account for the attenuated disease in Trem12/2 mice. In this
respect, it is noteworthy that the colonic LP of colitic Trem12/2
mice contained markedly fewer MHCIIint Ly6Chi cells or
inflammatory macrophages with the capacity for expression of
pro-inflammatory mediators [35,36].
As we have employed a CD4+ T cell-dependent colitis model
and indeed observed considerably reduced CD4+ T cell numbers
and correspondingly also mRNA levels for IFNc and IL-17 in the
colonic LP of transferred Trem12/2 x Rag22/2 mice, the question
arises whether deficiency in TREM-1 may directly impact the
priming of adaptive immune responses. Whereas in the colitis
model we have not analysed CD4+ T cell responses in more detail,
CD4+ T cells isolated from L. major-infected and CD8+ T cells
retrieved from influenza virus-infected Trem12/2 mice, respec-
tively, exhibited an unimpaired capacity for IFNc production
compared to T cells from Trem1+/+ mice.
The deciding role of neutrophils in the L. major infection model
[42] and the substantially decreased lesion size in Trem12/2 mice
have prompted us to investigate the impact of TREM-1 on
neutrophil-mediated functions in more detail. In particular, we
were interested in the potential modulatory effect of TREM-1
ligation on neutrophil survival as delayed neutrophil apoptosis
could also represent a critical pathogenic factor in intestinal inflam-
mation [45]. In agreement with a previous report [30], deficiency in
TREM-1 caused no intrinsic predisposition for increased sponta-
neous neutrophil apoptosis. However, agonistic TREM-1 stimulation
significantly promoted survival of SCF-condHoxb8 progenitor-
derived neutrophils in vitro. We have also sought to assess the
frequency of apoptotic neutrophils in Trem1+/+ versus Trem12/2
mice in situ by staining colonic tissue sections from colitic mice for
cleaved caspase 3 (data not shown). However, due to the likely very
rapid clearance of apoptotic neutrophils by intestinal phagocytes,
cleaved caspase 3 positive cells were rare in Trem1+/+ mice and
even more scarce in Trem12/2 mice. Moreover, the substantially
decreased cellular infiltrate in Trem12/2 mice further precluded an
objective comparison and quantification of apoptotic cells in situ.
While we cannot present definitive evidence that TREM-1
prolongs neutrophil survival in vivo, we still believe that the reduced
presence of neutrophils in Trem1-deficient mice in the CD4 T cell
induced colitis and L. major infection model relates to both: A
reduced secondary recruitment based on the diminished expression
of neutrophil chemotactic mediators and to a reduced life-span in
the absence of TREM-1 ligation, with the former mechanism
numerically perhaps being more relevant.
Considering the various effector cell types and mechanisms by
which TREM-1-mediated stimulation could contribute to disease,
it may appear intriguing that deficiency in TREM-1 did not
completely protect from disease. Accordingly, the degree of
protection from colitis was not much higher in Trem12/2 mice
compared to mice that were treated with the antagonistic LP17
peptide in our previous study [22]. We hypothesize that the
absence of complete protection in Trem12/2 mice may primarily
relate to the role of TREM-1 as an amplifier but not inducer of
pro-inflammatory reactions [3,5]. While we cannot rule out a
potential participation of TREM-3, we believe that the protective
effects seen in Trem12/2 mice are too substantial for a major
involvement of TREM-3 in the inflammatory models analysed.
One of the most striking findings of the present study was the
observation that microbial control in the models analysed was
apparently not impaired in Trem12/2 mice in spite of the blunted
inflammatory responses. Hence, while Tnf2/2 or anti-TNF-
treated mice exhibit an aggrevated acute DSS-induced colitis
[39,40] and also show enhanced parasite and bacterial burdens
upon infection with L. major and L. pneumophila, respectively
[41,53], Trem12/2 mice appeared equally capable of controlling a
parasitic, viral and bacterial infection as Trem1+/+ controls. This
observation is in line with the main function of TREM-1 as an
inflammatory fine-tuner which still allows for pro-inflammatory
TLR or NOD-like receptor-induced reactions in its absence.
Moreover, TREM-1 does not appear to be involved in phagocytic
or direct antimicrobial activity of myeloid cells [30,54,55]. Still,
conflicting data on the effect of a TREM-1 blockade on microbial
control have been reported from various bacterial challenge
models. Injection of a TREM-1/IgG fusion protein allowed for
sufficient control of an E. coli-induced peritoneal infection and
conferred protection [9] whereas maximal but not half-dose
siRNA silencing of TREM-1 increased mortality in a fecal
peritonitis model [29]. Similarly, administration of the antagonistic
LP17 peptide protected rats from a P. aeruginosa-induced pneu-
monia [28], whereas complete deficiency in TREM-1/3 led to
markedly increased mortality in Pseudomonas aeruginosa-challenged
mice due to defective transepithelial migration of neutrophils [30].
It has been proposed that the degree of TREM-1 blockade was a
likely critical parameter to account for these disparant findings
[29,30]. However, our findings demonstrate that microbial control
must not necessarily be impaired in mice with a complete
deficiency in TREM-1, even when employing a L. pneumophila
infection model where early neutrophil accumulation is also
crucial for bacterial clearance [49,50,51]. Thus, we speculate that
analogous to the divergent results obtained for endotoxin-
challenged DAP12-deficient mice [56,57], possibly the infection
dose, the nature of the microbial agent and/or the kinetics of the
infection may be critical parameters regarding the requirement for
Figure 9. Trem12/2 mice are equally capable of clearing L.
pneumophila as Trem1+/+ controls. Trem1+/+ and Trem12/2 mice
were infected intranasally with 56106 CFU L. pneumophila. 3 days post
infection CFU (A) and neutrophils (B) were quantified in the BALF. ns, no
statistically significant difference. Pooled data from two independent
experiments are shown.
doi:10.1371/journal.ppat.1003900.g009
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TREM-1. Accordingly, in the presence of low abundance and/or
low affinity TLR ligands or fast replicating agents, the inflamma-
tory response may more stringently depend on TREM-1-amplified
signaling. Alternatively, the expression of TREM-1 and its
association with DAP12 may only preferentially be induced in
situations of high abundance and/or high affinity TLR ligands
whereas low level signaling would favour the engagement of
TREM-2.
In summary, while the impact of TREM-1 on microbial control
still needs further investigations across different experimental
models, our extensive characterisation of Trem12/2 mice shows an
unanticipated prominent role for TREM-1 in parasitic and viral
infections. Our findings thus suggest that therapeutic targeting of
TREM-1 holds considerable promise for distinct non-infectious
and infectious inflammatory disorders and may bypass the
increased risk for impaired microbial control which is associated
with the general targeting of TNF.
Materials and Methods
Mice
Breedings and cohort maintenance were performed under SPF
conditions in isolated ventilated cages in the central animal facility
of the Medical School, University of Bern. All studies were
conducted with age- and sex-matched animals. Trem1+/+ mice that
were used as wildtype controls were originally derived from the
interbreeding of Trem1+/2 x Cre+/2 mice, thus carrying the
identical C57BL/6 genetic background and representing former
littermates of Trem12/2 mice. To nonetheless adjust for potential
differences in the microflora composition in Trem12/2 vs. Trem1+/
+ mice, the bedding of Trem1+/+ and Trem12/2 mice was regularly
exchanged between cages three weeks prior to the start of the
experiments.
Ethics statement
All animal experiments were approved by the Veterinary
Offices of the Cantons of Bern, Lausanne and Zurich and per-
formed in compliance with Swiss laws for animal protection.
Generation of Trem1-deficient mice
The generation of Trem1-deficient mice was designed and
carried out in collaboration with the TaconicArtemis GmbH
(Ko¨ln, Germany). To account for potential lethal effects of a total
deletion of the Trem1 gene and to allow for a possible cell-specific
ablation of Trem1 expression, a targeting vector was designed for
conditional deletion of exon 2, which encodes the extracellular
part of Trem1 and also contains the putative ligand binding site
[31]. As illustrated in the supplemental material Fig. S1, the
targeting vector was constructed on the basis of the cloning vector
KS loxP ftr Neo BS to flank exon 2 with loxP sites, to comprise
additional restriction sites (AseI and AvaI) and to contain PuroR
(flanked by F3 sites) and Neomycin (flanked by FRT sites) positive
selection marker cassettes to control for homologous recombina-
tion upstream and downstream of exon 2, respectively. For
counterselection, a Tk cassette was included downstream of exon
4. As a template for the PCR reactions a BAC-based plasmid
containing the entire genomic mouse Trem1 locus (RP23-32N8)
was obtained from BACPAC Resources Center BPRC (Oakland,
USA). The targeting vector was electroporated into a C57BL/
6N.tac embryonic stem cell line (TaconicArtemis). On day 2, cells
were selected with Puromycin and G418 and on day 8 counter-
selection with Gancyclovir was initiated. Isolated and expanded
ES clones were screened for complete integration of the targeted
allele by standard Southern blotting analyses with probes located
upstream of exon 1 (5e2) or exon 3 (ila1) (Fig. S1). Primer
sequences for generation of the 5e2 Southern probes were:
CGGATTTGACCAGGAATGACAG(sense) and CTTCCAG-
TTCATTCATGGACAGC (antisense) and for the ila1 Southern
probe: AGCTCCTCTTGTCTGCCATTCAAGGC (sense) and
GGCTACAACCTTGTTCTGCAG (antisense). Eight positive
clones could be identified and the ES clone A-A5 was subsequently
injected into Balb/c derived blastocytes which were then trans-
ferred to pseudopregnant NMRI females. Chimeric offspring were
bred to C57BL/6 female mice (C57BL/6-Tg(ACTB-Flpe)2Arte,
TaconicArtemis) transgenic for Flp recombinase to achieve
deletion of the FRT and F3 flanked selection cassettes PuroR
and Neomycin, respectively. Germline transmission of the targeted
Trem1 allele was identified by coat color contribution and by PCR
using oligo 1_sense (GTGCTCAGAGAATGTCTTTGTATCC)
and oligo 4_antisense (CCCTGGTCAGACCATTTACC) which
either yield a 1.3 kb fragment for the wildtype (WT) allele or a
1.6 kb fragment for the conditional Trem1flox allele. (Fig. S1). Cycling
conditions were: 59 at 95uC followed by 35 cycles consisting of 300 at
95uC, 300 at 60uC, 19 at 72uC, followed by 109 at 72uC. Thus
identified Trem1+/flox mice (C57BL/6-TREM-1tm1821_33.1Arte) were
mated with male mice carrying the Cre recombinase under the
control of the ROSA26 locus (C57BL/6-Gt(ROSA)26Sortm16(Cre)arte,
TaconicArtemis) to obtain systemic deletion of one Trem1 allele
(Trem1+/2). Trem1+/2 x Cre+/2 mice were interbred to achieve
deletion of Cre and to obtain wildtype controls (Trem1+/+) and
heterozygous (Trem1+/2) and homozygous (Trem12/2) Trem1-
deficient mice. Deletion of exon 2 in Trem1+/2 and Trem12/2 mice
was assessed by the genotyping PCR strategy described above and
depicted in Fig. S1.Trem1+/+ and Trem12/2mice were subsequently
expanded for experiments. For the CD4 adoptive transfer model of
colitis, Trem12/2 x Rag22/2 mice were generated by crossing
Trem12/2 mice with Helicobacter+ Rag22/2 mice and interbreed-
ing of the F1 offspring. The Helicobacter+ status of the Trem-12/2 x
Rag22/2 offspring was confirmed by PCR testing (Microbios
GmbH, Reinach, Switzerland).
Flow cytometry (FACS)
The following mAbs were used: anti-mouse CD11b-Pacific Blue
(M1/70), CD45-Pacific Blue (30-F11), CD45-Brilliant Violet570
(30-F11), CD4-APC-Cy7 (RM4-5), Gr1-PE (RB6-8C5), NK1.1-
PE-Cy7 (PK136), Ly6G-APC-Cy7 (1A8) and F4/80-biotin (BM8)
IL-7Ra-biotin (A7R34), CD3e-biotin (145-2C11) CD19-biotin
(6D11), Gr1-biotin (RB6-8C5) and Ter119-biotin (TER119), all
purchased from Biolegend; anti-mouse CD115-PE (AFS98), Gr1-
APC (RB6-8C5), CD45-eFluor605 (30-F11), CD45.1-PE (A20),
MHCII-APC (M5/114.15.2), CD11c-PE (N418), CD11b-
eFluor450 (M1/70), Streptavidin-PE-Cy7, were purchased from
eBioscience (San Diego, USA); anti-mouse Ly6C-FITC (AL-21)
from BD Pharmingen (San Diego, USA) and anti-mouse TREM-
1-APC (174031) from R&D Systems. DAPI (Invitrogen) was used
in a final concentration of 0.5 mg/ml to exclude dead cells. Prior to
FACS stainings, Fc receptors were blocked using supernatant from
the hybridoma 2.4G2. Cells were acquired on a LSRII SORP (BD
Biosciences, San Diego, USA) and analysed using FlowJo cyto-
metric analysis program (Tree Star, Ashland, USA).
Impact of TREM-1 on hematopoiesis
Analysis of hematopoietic stem cells and progenitors. For
FACS analysis of stem cell enriched LSK cells and myeloid
progenitors, and also for determination of colony-forming units, a
prior lineage depletion was performed using biotinylated mAbs
against red blood cell precursors (a-Ter119), B cells (a-CD19),
T cells (a-CD3e), myeloid cells (a-Gr1), MACS a-biotin beads, and
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LS columns (Miltenyi Biotec). Lymphoid progenitors were further
removed by adding anti-IL-7Ra-biotin.
Determination of colony forming units. 3.336103 lin2
cells were transferred into methocult base medium (M3134;
Stemcell Technologies) supplemented with 15% FCS, 20% BIT
(50 mg/ml BSA in IMDM, 1.44 U/ml recombinant-human (rh)
insulin (Actrapid, Novo Nordisk) and 250 ng/ml human holo
transferrin [Prospec]), 100 mM 2-b-mercaptoethanol, 2 mM l-
glutamine, penicillin/streptomycin, and 50 ng/ml recombinant-
mouse SCF (rmSCF), 10 ng/ml rm–IL-3, 10 ng/ml rh-IL-6 and
50 ng/ml rm-Flt3-ligand (all from Prospec). Colonies and cells
were enumerated after 7 days ($30 cells/colony).
Generation of mixed bone marrow chimeras. Congenic
(CD45.1+) recipient mice were irradiated in two split doses with
650 cGy in a 4 h interval in a Gammacell 40 exactor (Best
Theratronics). Total donor bone marrow (BM) was collected from
Trem12/2, Trem1+/+ and Trem1+/+ x GFP+/+ mice as described
below. Donor BM was mixed 1:1 and 156106 total cells of either
mixed Trem12/2 and Trem1+/+ x GFP+/+ BM cells or mixed
Trem1+/+ and Trem1+/+ x GFP+/+ BM cells were transferred in
200 ml PBS i.v. into the irradiated recipient mice. After transfer,
the recipients were treated with antibiotics (Baitryl and Bactrim) in
the drinking water for two weeks. After 10 weeks, the grade of
chimerism was controlled in the peripheral blood by calculating
the CD45.2+/CD45.1+ ratio. In all chimeras, the grade of
chimerism among the circulating myeloid cells was at least 99%.
Generation and analysis of SCF-dependent conditional
Hoxb8-immortalised progenitor cells and neutrophils
Generation of Hoxb8 progenitor lines and differentiation
of neutrophils. The protocol was adapted from the method
described by Wang et al. [44] with the major modification of using
a different inducible expression system [58]. In brief, bone
marrow-derived haematopoietic progenitors were isolated from
Trem1+/+ and Trem12/2 mice by magnetic bead-based lineage
depletion (BD IMagTM mouse hematopoietic progenitor cell
enrichment set-DM, BD Biosciences) following the manufacturer’s
instructions. 2–56105 lineage2 cells were incubated for 36 h in
complete RPMI Medium (RPMI 1640/Glutamax supplemented
with 10% FCS, 1% penicillin/streptomycin solution and 50 mM 2-
mercaptoethanol). Cells were then transduced with pF-56UAS-
Hoxb8(mm)-SV40-puro-GEV16 lentiviral particles by spin-infec-
tion (1000 rpm, 2 h, 30uC) in presence of 8 mg/ml polybrene.
Cells were subsequently cultured in complete RPMI medium
supplemented with SCF (added as 10% of CHO/SCF(mm)-
conditioned supernatant) and Hoxb8 expression was induced by
addition of 100 nM 4-OHT. Transduced cells were positively
selected with 1.0 mg/ml puromycin for a minimum of one month.
The resulting immortalized cell lines were termed SCF-condHoxb8.
For in vitro differentiation of SCF-condHoxb8 cells into mature
neutrophils, cells were washed twice in PBS to remove all traces of
4-OHT and were then replated at 20’000 cells/ml in complete
RPMI medium containing SCF (but no 4-OHT). Mature
neutrophils were thus obtained after 5–6 days as judged by
morphology and surface expression of CD11b and Gr-1, as well as
loss of c-kit (CD117) as determined by flow cytometry.
Apoptosis measurements. Spontaneous apoptosis of ma-
ture Trem1+/+ versus Trem12/2 neutrophils was assessed at 5 days
post differentiation in SCF-containing medium and 8 h, 24 h, and
48 h later. Immediately upon removal from plates, neutrophils
were washed in cold PBS and AnnexinV Binding Buffer and stained
with FITC-conjugated AnnexinV (BD Pharmingen) according to
the manufacturer’s instructions. DAPI (Sigma-Aldrich) was added
immediately prior to aquisition by flow cytometry. Only AnnexinV
and DAPI double-positive cells (AnnexinV+ DAPI+) were consid-
ered in the analysis of apoptotic cells. For determination of TREM-
1-mediated effects on apoptosis induction, 5 days differentiated
neutrophils were stimulated in vitro in 96-well U-bottom plates at
26105 cells/well in complete RPMI medium lacking SCF in the
presence of 10 mg/ml plate-bound anti-TREM-1 mAb (MAB1187;
R&D) or a respective isotype control (RTK2758, Biolegend) for
24 h. Since the relative stickiness of neutrophils activated by plate-
bound anti-TREM-1 did not allow for removal from the plates and
FACS-based analysis of AnnexinV+ DAPI+ cells without causing a
substantial bias by the selective analysis of non-adherent cells,
Caspase 3/7 activity was determined by the ApoTox-Glo assay
(Promega) according to manufacturer’s instructions.
Experimental animal models
CD4 T cell adoptive transfer model of colitis. Colitis was
induced in (Helicobacter-positive) Rag22/2 and Trem12/2 x
Rag22/2 mice by adoptive transfer of 26105 CD4+ CD252
CD45RBhi FACS-sorted T cells as described previously [59]. Mice
were sacrificed at 12–13 days post CD4 T cell transfer at the onset
of clinical signs of colitis (diarrhea, weight loss, symptoms of
abdominal pain) in Trem1+/+ mice.
Dextran sodium-sulfate (DSS)-induced colitis. Colitis was
induced in (Helicobacter-negative) Trem1+/+ and Trem12/2 mice
by administration of 3% 36’000–50’000 MW DSS (MP Biomed-
icals, Solon, USA) in the drinking water for 5 days followed by 4
days of regular tap water and euthanization at 9 days.
Leishmania major (L. major) infections. L. major LV39
(MRHO/Sv/59/P strain) parasites were maintained in vivo in
DBA/2J mice and further cultured in vitro in M199 medium
supplemented with 10% FCS, 4% HEPES and 2% antibiotics
(penicillin, streptomycin, neomycin). Mice were infected with
36106 parasites s.c. in the hind footpad in a final volume of 50 ml
as previously described [41]. Footpad lesion size was measured
with a Vernier caliper. The number of parasites in lesions were
evaluated by limiting dilution analysis [60].
Influenza virus infections. Influenza virus strain PR8 (A/
Puerto Rico/34 H1N1) was originally provided by J. Pavlovic
(University of Zurich, Switzerland). For infections, mice were
anaesthetized and inoculated intratracheally with 50 PFU influ-
enza virus in 50 ml endotoxin-free PBS. For collection of
bronchoalveolar lavage (BAL) fluid, lungs were flushed with
36400 ml PBS. To determine influenza viral titers in the lungs,
lungs were collected at the indicated time-points, homogenized
and serially diluted with MDCK cells as previously described [61].
Legionella pneumophila infections. L. pneumophila strain
JR32 (Philadelphia-1; sg1) (reference: PMID: 8225610) was grown
for 3 days on charcoal yeast extract (CYE) agar plates at 37uC and
resuspended in PBS prior to infection. Mice were anesthetized by
i.p. injection of 5 mg xylazine/100 mg ketamine per gram body
weight and infected intranasally with 56106 L. pneumophila. Three
days post infection, mice were sacrificed and perfused and
bronchoalveolar lavage fluid (BALF) was extracted with 1 ml
PBS, 5 mM EDTA. CFU were quantified by plating serial
dilutions on CYE agar plates and counted after 3 days incubation
at 37uC. BALF neutrophils were quantified by flow-cytometry.
Cell isolations
Spleen and peripheral blood. Blood was collected by tail
vain incision or by cardiac puncture into heparinised PBS. Spleen
cells were released by homogenization of spleens between the
frosted ends of two glass slides into PBS containing 5% horse
serum. Erythrocytes were depleted by brief incubation with ACK
lysis buffer.
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Bone marrow. Femurs and tibiae were removed and placed
in ice-cold PBS. Remaining flesh was removed and bones were
rinsed with sterile PBS. After opening of the bones, the BM was
flushed with a 26 GA 3/8 needle into RPMI 10% FCS.
Erythrocyte-depleted BM cells were either used for FACS-based
characterizations with or without prior lineage depletion or for the
generation of mixed BM chimeras.
Colonic lamina propria. Colons were opened longitudinally
and cut into small pieces. The epithelium was removed by
incubation in HBSS/HEPES containing 5% horse serum, 5 mM
EDTA and 2 mM DTT at 37uC for 3630 min under magnetic
stirring. Lamina propria (LP) cells were obtained by subsequent
digestion with 200 U/ml collagenase (Type IV; Sigma-Aldrich)
and 50 U/ml DNase (Type I, grade II; Roche) for 2645 min. The
LP fraction was filtered through a 40 mM cell strainer, counted by
Trypan Blue staining and further characterized by FACS.
Footpads. Footpads were digested using 1 mg/ml collage-
nase D in HBSS.
Histopathological analysis of mouse intestinal tissue
sections
To assess the presence of histopathological alterations on
formalin-fixed, paraffin-embedded and hematoxylin-eosin-stained
colonic tissue sections, a scoring system ranging from 0 (no
alterations) to 15 (most severe signs of colitis) was established,
including the following parameters: cellular infiltration (0–3), loss
of goblet cells (0–3), crypt abscesses (0–3), epithelial erosions (0–1),
hyperemia (0–2), thickness of the colonic mucosa (0–3). Histolog-
ical scoring was performed by a pathologist (V.G.) blinded to
sample identity.
RNA extractions and quantitative RT-PCR analyses
RNA was isolated using RNA isolation reagent (Tri-Reagent,
Molecular Research Center). DNA was digested using DNase I
(Ambion), and cDNA was generated using High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Expression of
genes was analysed using Qiagen Quantitect Primer Assays on a
7500 Real-time PCR System (AB Biosystems). The house keeping
gene GAPDH was used for normalization of gene expression.
Analysis of cytokines in supernatants and
bronchoalveolar lavage (BAL)
Cell-free supernatants derived from SCF2cond Hoxb8 neutro-
phils and BAL fluid from influenza virus infected mice were
analysed by ELISA (Biolegend).
Analysis of bone density
X-ray. High resolution X-ray analyses on anesthetized mice
were performed with the MX-20 Faxitron (X-ray Corporation,
Edimex, LePlessis, France).
MicroCT. For high resolution microcomputed tomography
(MicroCT) tissues were fixed in 4% paraformaldehyde in PBS for
24 h and subsequently transferred to 70% EtOH for mCT analysis
(MicroCT40, Scanco, Bruettisellen, Switzerland).
Statistical analyses
All data were analysed with GraphPad Prism software using the
Student’s t-test or 2-way ANOVA.
Supporting Information
Figure S1 Generation of Trem1-deficient mice. Trem1-
deficient mice were generated as described in detail in the
Materials and Methods section. In brief and as depicted in (A), a
targeting vector was designed for conditional deletion of exon 2
(coding for the extracellular V-type Ig-like domain) by flanking of
exon 2 with loxP sites. The targeting vector was further
constructed to contain additional restriction sites (AseI and AvaI),
the positive selection markers PuroR flanked by F3 sites and Neo
flanked by FRT sites and the counterselection cassette Tk. The
vector was electroporated into a C57BL/N.tac embryonic stem
(ES) cell line. Genomic DNA of selected ES clones was subjected
to enzymatic digestion with either AseI or AvaI and standard
Southern blotting analyses with probes located upstream of exon 1
(5e2) or exon 3 (ila1) to identify successful recombination or
presence of the correctly targeted allele, respectively. Balb/c-
derived blastocytes injected with the so identified targeted ES
clone A-A5 were then transferred to pseudopregnant NMRI
females and chimerism in the offsprings was assessed by coat
colour contribution (white/black). Chimeric offspring were bred to
C57BL/6 females transgenic for Flp to achieve Flp-mediated
removal of the F3 and FRT flanked PuroR and Neo selection
markers, respectively. Germline transmission was identified by the
presence of black C57BL/6 offspring, representing heterozygous
floxed Trem1 (+/flox) mice that possessed the conditional knockout
allele following Flp recombination. Trem1+/flox female mice were
mated with heterozygous Cre-transgenic (Cre+/2) ‘‘deleter’’ males
to generate Trem1+/2 mice with a heterozygous constitutive
knockout allele. Trem1+/2 x Cre+/2 mice were interbred to
generate fully Trem1-deficient (Trem12/2) mice. (A) Schematic
presentation of the Trem1 wildtype allele, the targeting vector, the
targeted allele before and after Flp recombination in vivo and the
final constitutive knockout allele after Cre recombination in vivo.
(B) Southern blot analyses of the ES clone A-A5 demonstrating
presence of the targeted allele (TA) following either digestion of
genomic DNA with AseI and hybridization with 5e2 probe or
digestion with AvaI and hybridization with ila1 probe. Restriction
enzyme and Southern blot hybridization sites are indicated in (A).
(C) A PCR-based genotyping strategy was developed to identify
presence of the wildtype allele, the conditional knockout allele in
Trem1+/flox mice and the knockout allele in Trem1+/2 mice. PCR
primer sites are indicated in (A).
(TIFF)
Figure S2 Composition of immune compartments in
Trem1+/+ and Trem12/2 mice. Peripheral blood (A), bone
marrow (B) and spleen cells (C) from 16 weeks old age- and sex-
matched Trem1+/+ (n = 3) and Trem12/2 mice (n = 3) were
characterized by FACS. Representative dot plots show the gating
strategies for identification of the respective cell subsets and graphs
show the mean values 6 SEM of total cell counts of n= 3 mice per
group.
(TIFF)
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